J Korean Med Sci.  2012 Mar;27(3):255-260. 10.3346/jkms.2012.27.3.255.

Health-Related Quality of Life Using the EuroQol 5D Questionnaire in Korean Patients with Type 2 Diabetes

• Lee WJ
• Song KH
• Noh JH
• Choi YJ
• Jo MW

• KMID: 1792995
• DOI: http://doi.org/10.3346/jkms.2012.27.3.255

Abstract

We aimed; 1) to determine the validity of the EuroQol 5D (EQ-5D) for the health-related quality of life (HRQOL) of Korean patients with type 2 diabetes, and 2) to identify associated factors of the HRQOL of these patients. Follow-up surveys were conducted for consecutive patients with type 2 diabetes. HRQOL was assessed using the EQ-5D and the Short Form-36 (SF-36). The validity of EQ-5D was assessed with the perspectives of known group, convergent and discriminant validity. Additionally, a linear mixed model using a backward elimination was used for identify associated factors. Of the 1,072 patients included in the first survey, 858 (80.0%) completed the questionnaires in the follow-up. In the known group validity, the problem rates in each EQ-5D dimension were highest among women, elderly people, and less-educated subjects. The Spearman's rho between the EQ-5D and the SF-36 scales were larger in the comparable dimensions than those in the less comparable dimensions. In the final model, we found that sex, age, education, body mass index, atrial fibrillation, stroke, and retinopathy were statistically significant. Our data suggest that the EQ-5D is a valid tool for Korean patients with type 2 diabetes and that various factors could affect their HRQOL.

Keyword

EQ-5D; Health-Related Quality of Life; Diabetes Mellitus, Type 2

MeSH Terms

Adult
Aged
Aged, 80 and over
Diabetes Mellitus, Type 2/complications/*physiopathology/psychology
Female
Humans
Male
Middle Aged
*Quality of Life
Quality-Adjusted Life Years
*Questionnaires
Republic of Korea
Young Adult

Figure

• 

  Fig. 1 Differences in eight SF-36 scales with regards to reports of "no problems" and "some or severe problems" in each EQ-5D domain. *P < 0.05. PF, physical functioning; RP, role-physical; BP, bodily pain; GH, general health; VT, vitality; SF, social functioning; RE, role-emotional; MH, mental health.

Reference

1. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998. 21:1414–1431.

2. Gregg EW, Cadwell BL, Cheng YJ, Cowie CC, Williams DE, Geiss L, Engelgau MM, Vinicor F. Trends in the prevalence and ratio of diagnosed to undiagnosed diabetes according to obesity levels in the US. Diabetes Care. 2004. 27:2806–2812.

3. Choi YJ, Kim HC, Kim HM, Park SW, Kim J, Kim DJ. Prevalence and management of diabetes in Korean adults: Korean National Health and Nutrition Examination Surveys 1998-2005. Diabetes Care. 2009. 32:2016–2020.

4. Kim DJ. The epidemiology of diabetes in Korea. Diabetes Metab J. 2011. 35:303–308.

5. Clarke PM, Hayes AJ, Glaszou PG, Scott R, Simes J, Keech AC. Using the EQ-5D index score as a predictor of outcomes in patients with type 2 diabetes. Med Care. 2009. 47:61–68.

6. Sakamaki H, Ikeda S, Ikegami N, Uchigata Y, Iwamoto Y, Origasa H, Otani T, Otani Y. Measurement of HRQL using EQ-5D in patients with type 2 diabetes mellitus in Japan. Value Health. 2006. 9:47–53.

7. Sakthong P, Charoenvisuthiwongs R, Shabunthom R. A comparison of EQ-5D index scores using the UK, US, and Japan preference weights in a Thai sample with type 2 diabetes. Health Qual Life Outcomes. 2008. 6:71.

8. Jo MW, Yun SC, Lee SI. Estimating quality weights for EQ-5D health states with time trade-off method in South Korea. Value Health. 2008. 11:1186–1189.

9. Redekop WK, Koopmanschap MA, Stolk RP, Rutten GE, Wolffenbuttel BH, Niessen LW. Health-related quality of life and treatment satisfaction in Dutch patients with type 2 diabetes. Diabetes Care. 2002. 25:458–463.

10. Lee AJ, Morgan CL, Morrissey M, Wittrup-Jensen KU, Kennedy-Martin T, Currie CJ. Evaluation of the association between the EQ-5D (health-related utility) and body mass index (obesity) in hospital-treated people with type 1 diabetes, type 2 diabetes and with no diagnosed diabetes. Diabet Med. 2005. 22:1482–1486.

11. Coffey JT, Brandle M, Zhou H, Marriott D, Burke R, Tabaei BP, Engelgau MM, Kaplan RM, Herman WH. Valuing health-related quality of life in diabetes. Diabetes Care. 2002. 25:2238–2243.

12. Lee YK, Nam HS, Chuang LH, Kim KY, Yang HK, Kwon IS, Kind P, Kweon SS, Kim YT. South Korean time trade-off values for EQ-5D health states: modeling with observed values for 101 health state. Value Health. 2009. 12:1187–1193.

13. Kang EJ, Shin HS, Park HJ, Jo MW, Kim NY. A valuation of health status using EQ-5D. Korea J Health Econ Policy. 2006. 12:19–43.

14. Dolan P. Modeling valuation for EuroQol health states. Med Care. 1997. 35:1095–1108.

15. Diabetes in Korea. 2007. Seoul: Korean Diabetes Association and Health Insurance Review and Assessment Service.